FDA to Decide on Approval of Prostate Cancer Vaccine
Vaccine and various other pharmaceutical manufacturers must conduct several tests and invest a substantial amount of money and time before the U.S. Food and Drug Administration (FDA) approves their product for patient and consumer use. A prostate-cancer vaccine, Provenge, has been 20 years in the making. If approved by the FDA, Provenge would represent a [...]